A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
The Impact of Treatment on Serum Level of Procalcitonin in Patients with Active Pulmonary Tuberculosis
J Cardiothorac Med
About one third of the world's population is infected with tuberculosis (TB) and each year, about 1.5 to 2 million people die from TB. Procalcitonin (PCT) is an inflammatory marker that its level has variable results. There are some discussions in the utilization of PCT as a diagnostic marker in active pulmonary TB. The aim of this study was to compare serum PCT before and after treatment in patients with pulmonary TB. Materials and Methods: This study was conducted on patients with pulmonaryfatcat:fr372cdj75afrivkcwevnhfqji